Helping you navigate at the intersection of policy and market access — focused on patient-first solutions.

Aery
Policy & Access
Partners

Aery Policy & Access Partners is a DC-based advisory consulting firm focused on today’s toughest pharmaceutical pricing and reimbursement issues, acting as a trusted advisor and facilitator of stakeholder solutions. Work is bespoke based on your specific concerns, building upon your existing strengths to facilitate optimal solutions.

My unique background spans roles
across various healthcare stakeholders.

Specialties

  • U.S. Government Payers at the Federaland State Levels

  • Drug Discounting and Rebating

  • 340B Subject Matter Expert

  • Policy Strategy Related to Drug Pricing or Market Access Concerns

  • Business Mitigation Solutions

  • Intersection of Global Drug Pricing and U.S. Evolving Policies

LEARN MORE

In the US and ex-US drug pricing environments, stakeholders are managing through an unprecedented amount of uncertainty as the rules and external environment are rapidly evolving.

Navigating Through Fog

Speaking Highlights

  • A one-day convening of scholars, policymakers, advocates, and industry stakeholders to examine the early implementation of the Inflation Reduction Act’s drug pricing provisions, and celebrate the anniversary of Medicare Part D.
    learn more >

  • The Association for Value Based Cancer Care’s 15th Annual Summit is on October 22-24, 2025. It brings together stakeholders and leaders for in-depth discussions, educations, and networking.
    learn more >